About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
2017 – Zydus started Phase II trial of ZYAN1 for treating anemia in patients with CKD
Post navigation
Previous:
2017 – Zydus received USFDA approval to initiate Phase II clinical studies of saroglitazar in patients with Primary Biliary Cholangitis (PBC)
Next:
2018 – Cadila Healthcare acquired 51% stake in Windlas Healthcare